Extrahepatic malignancy following long‐term immunosuppressive therapy of severe hepatitis B surface antigen‐negative chronic active hepatitis
Kenneth K. Wang, Albert J. Czaja, Sandra J. Beaver, Vay L. W. Go – 1 July 1989 – To determine the frequency, predisposing factors and consequences of extrahepatic malignancy following long‐term immunosuppressive therapy of severe HBsAg‐negative chronic active hepatitis, 149 patients who had received prednisone (20 mg daily) or prednisone (10 mg daily) in combination with azathioprine (50 mg daily) for at least 6 months were evaluated systematically for 109 ± 5 months (range: 7 to 223 months).